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Abstract
Purpose New guidelines recommend thrombectomy up to 24 h in selected patients; however, the workload and benefit of
extending time window are not known. We conducted a prospective single-centre study to determine the caseload, imaging
and interventional need of extended time window.
Methods All consecutive ischemic stroke patients within 24 h from onset in an 11-month period were included. Thrombectomy
eligibility in the 0–6 h time windowwas based on current guidelines; in the 6–24 h time window, it was based on a combination of
DEFUSE 3 and DAWN study criteria usingMRI to identify target mismatch. Clinical outcome in treated patients was assessed at 3
months.
Results Within 24 h of onset, 437 patients were admitted. In the 0–6 h time window, 238 patients (54.5%) arrived of whom 221
(92.9%) underwent CTA orMRA, 82 (34.5%) had large vessel occlusion (LVO), 30 (12.6%) had thrombectomy and 11 (36.6%)
became independent (mRS ≤ 2). In the extended 6–24 h time window, 199 patients (45.5%) arrived of whom 127 (63.8%)
underwent CTA or MRA, 44 (22.1%) had LVO, 8 (4%) had thrombectomy and 4 (50%) became independent.
Conclusion Extending the time window from 6 to 24 h results in a 26.7% increase in patients receiving thrombectomy and a
36.4% increase of independent clinical outcome in treated patients at the price of a significantly increased burden of clinical and
imaging screening due to the similar caseload but a smaller proportion of treatment eligible patients in the extended as compared
with the standard time window.
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Introduction
NewAHA [1] and ESO [2] guidelines recommend endovascular
treatment (EVT) of large vessel occlusion (LVO) strokes in an
extended time window of 6 to 24 h in patients selected with
advanced imaging, based on DAWN [3] and DEFUSE 3 [4]
trials. However, there are no published data from these trials
and only retrospective and speculative data from national regis-
tries or single centres [5–9] on the burden of screening these
patients, their treatment rates and outcomes as compared with
those in the standard time window within 6 h.
Aims
We conducted a prospective single-centre study to determine
the caseload, imaging and interventional need of acute stroke
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management in the extended as compared with the standard
time window.
Methods
All consecutive ischemic stroke patients admitted within 24 h
from onset to a large university hospital emergency room (ER)
from 01 February 2019 to 31 December 2019 were included.
Implementing the new guideline recommendations,
Emergency Medical Services protocol required all acute
stroke patients within 24 h to be urgently transported to our
stroke centre and ER also triaged these patients as critical. In
the 0–6 hour time window, all patients regardless of clinical
severity were considered for treatment. Patients with occlu-
sion of the internal carotid artery (ICA) and/or middle cerebral
artery (MCA) M1 segment with ASPECTS ≥ 6, or MCA M2
segment, ACAA1 segment, PCA P1 segment or basilar artery
were eligible for EVT. In the 6–24 h time window, only pa-
tients with NIHSS ≥ 6 or fluctuating/brainstem symptoms and
premorbid mRS ≤ 2 underwent CTA, and only those with
ICA, M1 and basilar occlusions were regarded as potentially
treatable LVO and underwent MRI to identify target mis-
match. Patients with unknown onset strokes recognised within
4 h had primary MRI. EVT eligibility was determined by
DEFUSE-3 criteria between 6-16 h and simplified DAWN
criteria between 16 and 24 h. See our detailed protocol in
Supplementary Figure. Time window, age, stroke severity
(NIHSS), non-invasive angiography use, presence of LVO
and EVT use were assessed. Clinical outcome (mRS) in the
subset of treated patients was assessed at 3 months. Patients in
the 0–6 and 6–24 time windows were compared with appro-
priate statistical tests.
Results
In this 11-month period, 437 ischemic stroke patients were
admitted within 24 h of onset (Fig. 1). Two hundred thirty-
eight patients (54.5%) arrived in the standard 0–6 hour time
window of whom 221 (92.9%) underwent CTA or MRA, 82
(34.5%) had LVO, 30 (12.6%) had EVT of whom 11 (36.6%)
became functionally independent (mRS < =2). Number need-
ed to screen (NNS) to find one EVT eligible patient was 8.
One hundred ninety-nine patients (45.5%) arrived in the
extended 6-24 h time window of whom 127 (63.8%)
underwent CTA or MRA, 44 (22.1%) had LVO, 8 (4%) had
EVT of whom 4 (50%) became functionally independent
(mRS < =2). NNS to find one EVT eligible patient was 25.
Patients in the two time windows were comparable in num-
bers, with similar age and sex ratio (Table 1). Patients in the
standard time window had more severe strokes (median
NIHSS 6 vs 5; p = 0.011), had LVO more often (34.5 vs
22.1%; p = 0.0046), were eligible for EVT more often (12.6
vs 4%; p = 0.001), and had greater proportion of EVT eligi-
bility in case of LVO (36.6 vs 18.2%, p = 0.0415). Treated
patients in the two time windows had similar age, but those in
the standard time window had more severe strokes (median
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Fig. 1 Flowchart in standard and extended time windows
604 Neuroradiology (2021) 63:603–607
NIHSS 15 vs 8) and worse clinical outcome (median mRS 4
vs 2.5) not reaching statistical significance because of low
numbers (Table 2). 65.1% of LVO strokes and 78.9% of
EVT eligible patients were in the 0–6 hour time window.
The extension of time window translated into an 83.6% in-
crease in patient numbers for emergency clinical screening, a
57.5% increase in non-invasive angiography, a 26.7% in-
crease in EVT and a 36.4% increase of independent clinical
outcome in treated patients.
Discussion
In our management environment implementing new guide-
lines on extended time window, 45.5% of all stroke patients
within 24 h arrived beyond 6 h. This is a larger proportion than
in retrospective studies from before current guidelines
reporting 35% [6] and 33% [8].
In the 0–6 hour time window, the rate of LVO was high
(34.5%) and the rate of EVT (12.6%) was higher than the post
hoc calculated EVT eligibility (10.5%) from a single-centre
registry with similar selection criteria, but before the evidence-
based thrombectomy era (2003–2014) [8].
In the 6–24 hour time window, the rate of LVO (22.1%)
was similar, but the rate of EVT (4%) was lower in our study
than in a retrospective analysis [7] (19.6% and 9.2% respec-
tively) using similar DAWN + DEFUSE 3 criteria. However,
data on patients managed outside trial criteria and not re-
ferred to the tertiary centre were not available for
comparison; therefore, we expect selection bias towards
LVO patients more likely to be eligible for intervention.
EVT rate in our study was comparable to eligibility esti-
mates by Lee et al (3.6%) [6].
EVT rate in our patients was significantly lower in the
extended than in the standard time window (4 vs 12.6%).
This is due to both a lower rate of LVO (22.1 vs 34.5 %)
and a lower rate of EVT in LVO strokes (18.2 vs 36.6%).
Lower rate of LVO may be explained by the following: (1) a
lower rate of non-invasive angiography (63.8 vs 92.2%) as
mild strokes (NIHSS < 6) were not candidates for CTA; there-
fore, LVOs causing only mild symptoms may have been
missed. (2) Stricter definition of treatment eligible LVO (only
ICA, M1 and BA) and (3) the fact that more severe strokes
with higher NIHSS and higher probability of LVO are more
alarming and thus prompt earlier presentation at ER. Indeed,
NIHSS was significantly lower in the late time group (median
5 vs 6, p = 0.011). The lower rate of EVT in LVO strokes is
due to stricter imaging eligibility criteria beyond 6 h: higher
ASPECTS, smaller core and demonstration of penumbra that
rapidly decreases with time. EVT eligibility may improve if
ongoing studies (TENSION, IN-EXTREMIS) show benefit
with more relaxed selection criteria such as milder strokes
and larger infarct cores; however, “time is brain” remains a
valid and important concept on a population basis.
We found that treatment outcome was better in the extend-
ed than in the standard time window (median mRS 2.5 vs 4)
that probably reflects both lower stroke severity (median
NIHSS 8 vs 15) and stricter imaging criteria in this group;
Table 1 Comparison of all
patients in standard and extended
time windows
0–6 h 6–24 h p
Number of cases 238 199 n.a.
Male (%) 50 49.7 0.96 (chi-square)
Age (mean, SD) 70.5 (± 12.4) 70.9 (± 11.7) 0.744 (t test)
NIHSS (median, IQR) 6 (4–12) 5 (3–8) 0.011 (Mann-Whitney)
CTA/MRA (%) 92.9 63.8 < 0.001 (chi-square)
LVO (%) 34.5 22.1 0.0046 (chi-square)
EVT (%) 12.6 4 0.001 (Fisher)
EVT in LVO (%) 36.6 18.2 0.0415 (Fisher)
NNS for EVT 8 25 n.a.
Table 2 Comparison of treated
patients in standard and extended
time windows
0–6 h 6–24 h p
Number of EVTs 30 8 n.a.
Age (mean, SD) 68.2 (± 12.2) 69.1(± 14.4) 0.855 (t test)
NIHSS (median, IQR) 15 (9–18) 8 (5–15) 0.086 (Mann-Whitney)
mRS (median, IQR) 4 (1–6) 2.5 (0–5) 0.44 (Mann-Whitney)
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however, due to small numbers, these differences did not
reach statistical significance. Independent clinical outcome
(mRS ≤ 2) was seen in 50% of our treated patients in the 6–
24 h group that is similar to the landmark studies (DAWN:
49%, DEFUSE 3: 45%) [3, 4].
Our study reports a larger burden of screening to find EVT
eligible patients (NNS 25) than that of Jadhav et al. [7] (NNS
11) with similar selection criteria but in a pre-selected patient
population. In our study, the extension of time window led to a
slightly smaller increase in actually treated patients (26.7%)
than the 33.3% increase of theoretically EVT eligible patients
from a retrospective analysis of a single-centre registry [5]. Our
results—in line with previous studies [5–7], and [9] comparing
pre- and post-DAWN management—show that the main bur-
den of extended time window lies on the clinical and imaging
screening of patients (EMS, ER, neurologists and radiologists)
rather than their treatment because of the smaller proportion of
EVT eligible patients compared with the standard time win-
dow. This needs to be taken into account when planning
stroke care pathways and resource allocation. However, a
more than 25% increase in EVT rate is clinically important,
and late thrombectomy up to 24 h was shown to be both
clinically highly efficacious [3, 4] and cost-effective [10].
We also demonstrated good clinical outcomes in the late
time window in 50% of patients similar to the landmark
studies [3, 4]. Therefore, we recommend that patients in
the extended time window should also be actively screened
for thrombectomy.
We believe that our results more precisely reflect current
real life situation than previous retrospective analyses because
our data are based on a prospective study of unselected pa-
tients in a current guideline–driven stroke management
system.
The main limitation of our study is its single-centre design
and the small number of treated patients precluding firm con-
clusions on outcomes.
Conclusion
Extending the time window from 6 to 24 h for thrombectomy
results in a more than 25% increase in patients receiving
thrombectomy at the price of a significantly increased bur-
den of clinical and imaging screening due to the smaller
proportion of treatment eligible patients beyond 6 h based
on current strict eligibility criteria. However, late patients
benefit at least equally from treatment; therefore, we rec-
ommend that they should also be actively screened. Further
studies are needed to evaluate the benefit of thrombectomy
beyond 6 h with less strict imaging and clinical criteria.
Efforts should be made to achieve earlier patient arrival,
because “time is brain” is still an important paradigm on a
population level.
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